SOD1 and amyotrophic lateral sclerosis: Importantly, we identified a core set of genes that were consistently altered in VCP mutant microglia, postmortem ALS spinal cord, and SOD1 mutant mice, which may represent attractive therapeutic targets to modulate microglial dysfunction in ALS.